UA83888C2 - Фармацевтическая композиция винфлунина, предназначенная для парентерального введения, способ получения и применение - Google Patents

Фармацевтическая композиция винфлунина, предназначенная для парентерального введения, способ получения и применение

Info

Publication number
UA83888C2
UA83888C2 UAA200608219A UAA200608219A UA83888C2 UA 83888 C2 UA83888 C2 UA 83888C2 UA A200608219 A UAA200608219 A UA A200608219A UA A200608219 A UAA200608219 A UA A200608219A UA 83888 C2 UA83888 C2 UA 83888C2
Authority
UA
Ukraine
Prior art keywords
vinflunine
pharmaceutical composition
preparation
same
parenteral administration
Prior art date
Application number
UAA200608219A
Other languages
English (en)
Ukrainian (uk)
Inventor
Эли ЛЕВЕР
Жоэль БУГАРЕ
Мари-Доминик Ибарра
Original Assignee
Пьер Фабр Медикаман
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34630533&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA83888(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пьер Фабр Медикаман filed Critical Пьер Фабр Медикаман
Publication of UA83888C2 publication Critical patent/UA83888C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение касается фармацевтической композиции винфлунина в форме стабильного и стерильного водного раствора водорастворимой соли винфлунина, значения рН которого составляет от 3 до 4, при этом указанная композиция не содержит консервантов. Изобретение также касается способа получения указанной композиции и ее применения в качестве лекарственного средства для парентерального введения при лечении рака.
UAA200608219A 2003-12-23 2004-12-17 Фармацевтическая композиция винфлунина, предназначенная для парентерального введения, способ получения и применение UA83888C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0315312A FR2863891B1 (fr) 2003-12-23 2003-12-23 Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
PCT/FR2004/003287 WO2005070425A1 (fr) 2003-12-23 2004-12-17 Composition pharmaceutique de vinflunine destinee a une administration parenterale, procede de preparation et utilisation

Publications (1)

Publication Number Publication Date
UA83888C2 true UA83888C2 (ru) 2008-08-26

Family

ID=34630533

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200608219A UA83888C2 (ru) 2003-12-23 2004-12-17 Фармацевтическая композиция винфлунина, предназначенная для парентерального введения, способ получения и применение

Country Status (35)

Country Link
US (1) US20070155768A1 (ru)
EP (1) EP1696913B1 (ru)
JP (2) JP5226220B2 (ru)
KR (1) KR101166347B1 (ru)
CN (2) CN101695474A (ru)
AR (1) AR047346A1 (ru)
AT (1) ATE424201T1 (ru)
AU (1) AU2004314154B2 (ru)
BR (1) BRPI0418005B8 (ru)
CA (1) CA2551493C (ru)
CR (1) CR8473A (ru)
CY (1) CY1109120T1 (ru)
DE (1) DE602004019809D1 (ru)
DK (1) DK1696913T3 (ru)
EC (1) ECSP066663A (ru)
ES (1) ES2323374T3 (ru)
FR (1) FR2863891B1 (ru)
HK (1) HK1089105A1 (ru)
IL (1) IL176404A (ru)
MA (1) MA28237A1 (ru)
MX (1) MXPA06007208A (ru)
MY (1) MY139643A (ru)
NI (1) NI200600146A (ru)
NO (1) NO336427B1 (ru)
NZ (1) NZ548028A (ru)
OA (1) OA13348A (ru)
PL (1) PL1696913T3 (ru)
PT (1) PT1696913E (ru)
RU (1) RU2362557C2 (ru)
SI (1) SI1696913T1 (ru)
TN (1) TNSN06197A1 (ru)
TW (1) TWI334352B (ru)
UA (1) UA83888C2 (ru)
WO (1) WO2005070425A1 (ru)
ZA (1) ZA200605201B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
FR2910812B1 (fr) * 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
EP1997534A1 (en) * 2007-05-31 2008-12-03 Pierre Fabre Medicament Cancer treatment combination therapy comprising vinflunine and trastuzumab
CN101129374B (zh) * 2007-06-26 2010-09-08 齐鲁制药有限公司 长春氟宁药物组合物及其制备方法与应用
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
CN101607968A (zh) * 2008-06-17 2009-12-23 江苏豪森药业股份有限公司 长春氟宁盐、其制备方法及其药物组合物
KR101844623B1 (ko) * 2011-03-29 2018-04-02 사노피 안정성이 향상된 오타믹사반 제제
EP3328385B1 (en) * 2015-08-01 2020-07-08 Sun Pharmaceutical Industries Ltd Dosage form of vinca alkaloid drug
EP3481422A1 (en) * 2016-07-06 2019-05-15 Pierre Fabre Medicament Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307100A (en) * 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
CA2001643A1 (en) * 1988-12-23 1990-06-23 Richard L. Wolgemuth Preservative-free multi-dose vincristine solution
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
JPH06100452A (ja) * 1993-04-06 1994-04-12 Asta Medica Ag イホスファミド用の製薬学的容器
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
DE19706255C2 (de) * 1997-02-18 2000-11-30 Schott Glas Sterilisierbarer Glasbehälter für medizinische Zwecke, insbesondere zur Aufbewahrung pharmazeutischer oder diagnostischer Produkte
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
JP3642492B1 (ja) * 2003-10-31 2005-04-27 小野薬品工業株式会社 オザグレルナトリウム含有水溶液を充填してなる注射用容器
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation

Also Published As

Publication number Publication date
FR2863891A1 (fr) 2005-06-24
AR047346A1 (es) 2006-01-18
OA13348A (fr) 2007-04-13
ES2323374T3 (es) 2009-07-14
BRPI0418005B1 (pt) 2019-11-26
NI200600146A (es) 2006-12-12
ATE424201T1 (de) 2009-03-15
CN1897940A (zh) 2007-01-17
SI1696913T1 (sl) 2009-08-31
AU2004314154A1 (en) 2005-08-04
IL176404A0 (en) 2006-10-05
US20070155768A1 (en) 2007-07-05
WO2005070425A1 (fr) 2005-08-04
MXPA06007208A (es) 2006-08-18
FR2863891B1 (fr) 2006-03-24
CA2551493A1 (fr) 2005-08-04
DE602004019809D1 (de) 2009-04-16
CY1109120T1 (el) 2014-07-02
AU2004314154B2 (en) 2011-03-24
ECSP066663A (es) 2006-10-25
CA2551493C (fr) 2012-12-04
TW200531717A (en) 2005-10-01
DK1696913T3 (da) 2009-06-29
ZA200605201B (en) 2007-09-26
NZ548028A (en) 2010-01-29
MY139643A (en) 2009-10-30
JP5710462B2 (ja) 2015-04-30
EP1696913B1 (fr) 2009-03-04
PL1696913T3 (pl) 2009-08-31
NO336427B1 (no) 2015-08-17
BRPI0418005A (pt) 2007-04-17
JP2007515461A (ja) 2007-06-14
MA28237A1 (fr) 2006-10-02
BRPI0418005B8 (pt) 2021-05-25
PT1696913E (pt) 2009-06-05
EP1696913A1 (fr) 2006-09-06
TNSN06197A1 (fr) 2007-11-15
KR20060124624A (ko) 2006-12-05
CN101695474A (zh) 2010-04-21
CR8473A (es) 2006-11-24
KR101166347B1 (ko) 2012-07-18
NO20063277L (no) 2006-07-14
IL176404A (en) 2010-11-30
JP2012102120A (ja) 2012-05-31
HK1089105A1 (en) 2006-11-24
JP5226220B2 (ja) 2013-07-03
RU2006126708A (ru) 2008-01-27
RU2362557C2 (ru) 2009-07-27
TWI334352B (en) 2010-12-11

Similar Documents

Publication Publication Date Title
NO20063277L (no) Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav
NZ543661A (en) Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation
AP1760A (en) Platinum derivative pharmaceutical formulations.
MY141584A (en) Pharmaceutical uses of bisphosphonates
TW200500067A (en) Salts of codrugs and uses related thereto
MY140398A (en) 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES
MXPA03010402A (es) Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina.
GB0211649D0 (en) Organic compounds
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
MXPA02001254A (es) Formulacion de moxifloxacino con sal-comun.
WO2006131923A3 (en) Novel salts of conjugated psychotropic drugs and processes of preparing same
SE0300098D0 (sv) Use of cyclin D1 inhibitors
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
PT1718651E (pt) Derivados 7h-pirrolopirimidina
SE0301577L (sv) Lösning med låg natriumhalt
AU6011001A (en) Novel lhrh-antagonists, production and use thereof as medicament
NO20055998L (no) Diarylmetylidenpiperidinderivater, preparater derav og anvendelse derav
WO2005049483A3 (de) Reaktive chlorverbindungen, deren derivate, anionen und salze sowie verfahren zu deren herstellung und verwendung
PT1572686E (pt) Derivados de amida do ácido antranílico e suas utilizações farmacêuticas
UA11061U (ru) Способ местного лечения туберкулезных эмпием плевральной полости
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
MXPA05005919A (es) Composiciones de ifosfamida para la administracion parenteral, y un proceso para su preparacion.
UA36756A (ru) СПОСОБ ЛЕЧЕНИЯ больныХ со злокачественными опухолями молочной железы